A detailed history of Farther Finance Advisors, LLC transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Farther Finance Advisors, LLC holds 23 shares of ADPT stock, worth $145. This represents 0.0% of its overall portfolio holdings.

Number of Shares
23
Previous 48 52.08%
Holding current value
$145
Previous $173,000 31.79%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$3.37 - $5.12 $84 - $128
-25 Reduced 52.08%
23 $118,000
Q2 2024

Jul 31, 2024

BUY
$2.34 - $3.96 $53 - $91
23 Added 92.0%
48 $173,000
Q1 2024

May 13, 2024

SELL
$2.88 - $4.8 $74 - $124
-26 Reduced 50.98%
25 $78,000
Q4 2023

Feb 14, 2024

BUY
$3.46 - $5.33 $442 - $682
128 New
128 $627,000
Q1 2023

May 13, 2024

SELL
$7.8 - $10.11 $600 - $778
-77 Reduced 60.16%
51 $450,000
Q4 2022

Sep 11, 2023

BUY
$6.26 - $9.34 $319 - $476
51 New
51 $390,000

Others Institutions Holding ADPT

About Adaptive Biotechnologies Corp


  • Ticker ADPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 142,872,992
  • Market Cap $903M
  • Description
  • Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...
More about ADPT
Track This Portfolio

Track Farther Finance Advisors, LLC Portfolio

Follow Farther Finance Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Farther Finance Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Farther Finance Advisors, LLC with notifications on news.